|
Quotes & Info
|
| APPY > SEC Filings for APPY > Form 8-K on 7-Feb-2013 | All Recent SEC Filings |
7-Feb-2013
Regulation FD Disclosure, Financial Statements and Exhibits
On February 7, 2013, Venaxis, Inc. (the "Company") issued a press release titled
- "Venaxis Executes First Commercial Development Agreement and Receives Purchase
Order from EMELCA Bioscience for Initial EU Launch." The press release is
furnished as Exhibit 99.1 to this Form 8-K.
(d) Exhibits.
Exhibits
99.1 Press Release of Venaxis, Inc. titled "Venaxis Executes
First Commercial Development Agreement and Receives
Purchase Order from EMELCA Bioscience for Initial EU
Launch," issued February 7, 2013.
|
|
|